When DNMT1 transcript levels in the tissue and blood samples from the AD patients were compared with those from the control group, it was found that the DNMT1 levels in the tissue samples were similar between AD patients and the control group, with no significant difference. This evidence concerns the gene DNMT1 and Alzheimer disease.